ADMA Biologics, Inc. (ADMA)

19.49 -0.39 (-1.96%) USD  |  NASDAQ  |  Dec 23, 16:00
19.50 +0.01 (+0.05%) Pre-Market: 08:51
More

ADMA Biologics SG&A Expense (TTM): 96.37M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 523.36M
Vanda Pharmaceuticals, Inc. 214.26M
Aldeyra Therapeutics, Inc. 9.186M
Arcutis Biotherapeutics, Inc. 253.18M
Exelixis, Inc. 530.03M